Table 1.
Clinical Summary
| Date | PSA (ng/mL) |
T (ng/dL) |
Treatment |
|---|---|---|---|
| 9/09 | 0.2 | Biopsy for abnormal DRE revealed HGPIN in 1 of 12 cores | |
| 4/10 | 0.2 | ||
| 6/11 | 0.43 | ||
| 3/12 | 0.3 | ||
| 5/13 | 0.43 | 47 | DRE normal, started TRT, scheduled biopsy |
| 6/13 | 533 | Biopsy revealed Gleason grade 4+4=8 CaP; TRT stopped | |
| 9/13 | Radical prostatectomy | ||
| 11/13 | <0.03 | ||
| 12/13 | <0.03 | 23 | Restarted TRT |
| 1/14 | <0.03 | 162 | |
| 5/14 | 661 | ||
| 8/14 | 0.05 | 1026 | |
| 2/15 | <0.03 | 929 | |
| 8/15 | 0.04 | 496 | |
| 2/16 | 0.06 | 314 |
Abbreviations: CaP, prostate cancer; DRE, digital rectal examination; HGPIN, high-grade prostatic intraepithelial neoplasia; PSA, prostate-specific antigen; T, testosterone; TRT, testosterone replacement therapy.